# DESCRIPTION

## GRANTS

- acknowledge government grants

## BACKGROUND

- describe parasitic diseases

## SUMMARY

- introduce mTOR and PI3K inhibitors
- describe method of treating trypanosomatid parasites
- outline various formulae for inhibitor compounds

## DESCRIPTION

- introduce target repurposing

### DEFINITIONS

- define alkyl
- define alkenyl
- define alkynyl
- define cycloalkyl
- define cycloalkenyl
- define aryl
- define heterocycle
- define alkylamino
- define terms
- describe salt formation
- discuss prodrugs and stereoisomers
- define compounds and isomers
- describe functional groups and chemical terms
- introduce isotopically labeled compounds
- define substituents and functional moieties
- describe target of rapamycin (TOR) and its role in trypanosomatid parasites
- discuss trypanosomatid genomes and PI3K protein superfamily

### Methods of Treatment

- describe method of treating disease caused by trypanosomatid parasite
- define therapeutically effective amount
- describe structure of Formula (I)
- describe structure of Formula (VI)
- describe structure of Formula (VII)

### Methods of Preparation

- describe general synthetic schemes for manufacturing compounds

### Step 1

- describe reaction of pyrido[2,3-d]pyrimidine I′ with amine II′

### Step 1

- describe reaction of substituted 1H-pyrazolo[3,4-d]pyrimidine VII′ with indole VIII′

### Step 1

- describe condensation reaction of aldehyde IX′ with hydrazine X′

### Step 1

- outline synthesis steps

### Step 1

- outline alternative synthesis steps

### Pharmaceutical Compositions

- define pharmaceutical compositions
- describe pharmaceutically acceptable carriers
- discuss pharmaceutically acceptable salts
- list accessory ingredients
- outline methods of preparing formulations
- describe solid dosage forms
- describe liquid dosage forms
- describe pharmaceutical compositions
- formulate compositions for administration
- administer compositions to subjects
- prepare pharmaceutical pack or kit
- describe modes of administration
- discuss delivery systems

## EQUIVALENTS

- disclaim limitation of examples

## Examples

- test potency of PI3K inhibitors against trypanosomatid parasites

### Materials and Methods

- describe ethics statement and animal study approvals

### Compounds

- list sources of inhibitor compounds

### In Vitro Experiments

- describe potency assessment against T. brucei and T. cruzi
- analyze morphological and cell cycle alterations from compound treatment

### In Vivo Experiments.

- describe drug dosage and in vivo experiments for T. brucei, T. cruzi, and L. major

### Results

- select compounds for profiling
- describe in vitro testing of inhibitors
- present effects of compounds on human and trypanosome cells
- describe phenotypic effects elicited by PI3K inhibitor treatments
- examine effects on cell size and DNA content
- describe in vivo tests of NVP-BEZ235
- discuss results and implications for medicinal chemistry optimization
- summarize findings and suggest future directions

## EQUIVALENTS

- statement on equivalents to specific embodiments

